-
(2S,4R)-1-(2-Aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid
-
BD631047943134-39-298%
-
¥4041.050mg
-
(2S,5S,8S,11S,14S,17S)-17-((2S,3S)-2-((S)-5-Amino-2-((S)-2,6-diaminohexanamido)-5-oxopentanamido)-3-methylpentanamido)-2,8,11-tris(4-aminobutyl)-5-benzyl-14-((S)-sec-butyl)-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazaicosane-1,20-dioic acid
-
BD012369431507930-57-598%
-
¥2987.0250mg
-
2-((2,6-Dichloro-3-methylphenyl)amino)benzoic acid
-
BD137316644-62-295%
-
¥1062.05mg
-
Gap 26
-
BD01071376197250-15-098%
-
¥513.05mg
-
(2R,4S)-1-(Acetyl-D-tyrosyl-D-prolyl)-N-(2-(((R)-1-((2-amino-2-oxoethyl)amino)-1-oxopropan-2-yl)amino)-2-oxoethyl)-4-hydroxypyrrolidine-2-carboxamide
-
BD01296574355151-12-198%
-
¥897.010mg
-
Larazotide acetate
-
BD00842408881851-50-998%
-
¥1206.0100mg
-
(2S,4R)-4-Benzamido-1-glycylpyrrolidine-2-carboxylic acid hydrochloride
-
BD370306943133-81-199%
-
¥1247.05mg
-
TAT-Gap19 TFA
-
BD0186087998%
-
¥
-
2-((S)-1-((2S,5S,8S,11S)-17-Amino-2-(3-amino-3-oxopropyl)-8-isobutyl-5,11-diisopropyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazaheptadecan-1-oyl)pyrrolidine-2-carboxamido)acetic acid
-
BD01328232258818-34-797%
-
¥
-
Tonabersat
-
BD154391175013-84-098+%
-
¥3763.010mg
-
((S)-2-(2-((2S,3S)-2-((R)-2-((S)-2-Amino-3-phenylpropanamido)-3-mercaptopropanamido)-3-methylpentanamido)acetamido)-5-((diaminomethylene)amino)pentanoyl)-L-leucine compound with 2,2,2-trifluoroacetic acid
-
BD01517461N/A98%
-
¥
-
L-Phenylalanyl-L-cysteinyl-L-isoleucylglycyl-L-arginyl-L-leucine
-
BD734222835872-35-097%
-
¥2449.01g